Wave Operating Cycle from 2010 to 2026
| WVE Stock | USD 13.43 0.49 3.79% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 4.31 | Current Value 4.1 | Quarterly Volatility 159.13357994 |
Check Wave Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Wave Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.8 M, Interest Expense of 1.8 M or Selling General Administrative of 36.3 M, as well as many indicators such as Price To Sales Ratio of 17.25, Dividend Yield of 0.0 or PTB Ratio of 8.92. Wave financial statements analysis is a perfect complement when working with Wave Life Valuation or Volatility modules.
Wave | Operating Cycle | Build AI portfolio with Wave Stock |
Analyzing Wave Life's Operating Cycle over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Operating Cycle has evolved provides context for assessing Wave Life's current valuation and future prospects.
Latest Wave Life's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of Wave Life Sciences over the last few years. It is Wave Life's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Wave Life's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
Wave Operating Cycle Regression Statistics
| Arithmetic Mean | 111.48 | |
| Geometric Mean | 45.79 | |
| Coefficient Of Variation | 142.74 | |
| Mean Deviation | 108.34 | |
| Median | 67.93 | |
| Standard Deviation | 159.13 | |
| Sample Variance | 25,323 | |
| Range | 541 | |
| R-Value | 0.09 | |
| Mean Square Error | 26,814 | |
| R-Squared | 0.01 | |
| Significance | 0.74 | |
| Slope | 2.70 | |
| Total Sum of Squares | 405,176 |
Wave Operating Cycle History
About Wave Life Financial Statements
Wave Life stakeholders use historical fundamental indicators, such as Wave Life's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Wave Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in Wave Life's assets and liabilities are reflected in the revenues and expenses on Wave Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Wave Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 4.31 | 4.10 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Wave Life Sciences is a strong investment it is important to analyze Wave Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Wave Life's future performance. For an informed investment choice regarding Wave Stock, refer to the following important reports:Check out the analysis of Wave Life Correlation against competitors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Pharmaceuticals sector continue expanding? Could Wave diversify its offerings? Factors like these will boost the valuation of Wave Life. Anticipated expansion of Wave directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Wave Life data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.65) | Revenue Per Share | Quarterly Revenue Growth (0.56) | Return On Assets | Return On Equity |
Understanding Wave Life Sciences requires distinguishing between market price and book value, where the latter reflects Wave's accounting equity. The concept of intrinsic value—what Wave Life's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Wave Life's price substantially above or below its fundamental value.
Please note, there is a significant difference between Wave Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Wave Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Wave Life's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.